Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

liam-burnett-blue-t7xx-ko7vso-unsplash

Asia’s COVID-19 deaths surpass one million

March 11, 2022 Medical Communications

A Reuters tally has revealed that Asia passed the milestone of one million coronavirus-linked deaths on Friday 11 March. A …
News

WHO advises Ukraine to destroy disease-causing pathogens in labs

March 11, 2022 Medical Communications

WHO has advised Ukraine to destroy “disease-causing pathogens” kept in public health labs, to prevent “any potential spills”, Reuters has …
News

NIHR unites with health and social care leaders to improve public research involvement

March 11, 2022 Medical Communications

The National Institute for Health Research (NIHR) has announced a new shared commitment to improve public health in research. The …
News

Phase III trial into nirsevimab for RSV treatment yields positive results

March 4, 2022 Medical Communications

The latest results from Sanofi and AstraZeneca’s Phase III trial nirsevimab support the vaccine’s ability to protect all infants from …
News

Median Technologies iBiopsy Lung Cancer Screening Software

March 4, 2022 Medical Communications

Median Technologies has announced that the company has filed a regulatory submission to the FDA for its iBiopsy Lung Cancer …
News

Promising treatment targeting 40% mortality Candida infection

March 4, 2022 Medical Communications

A Promising Innovation Medicine (PIM) designation has been awarded to rezafungin by the MHRA, for the treatment of invasive candidiasis. …
News

Anti-inflammatory baricitinib is a life-saving COVID-19 drug

March 4, 2022 Medical Communications

UK experts say they have identified another life-saving drug that can alleviate COVID-19 illness. The anti-inflammatory baricitinib is usually used …
News

Risk of hospitalisation five times higher with J&J

March 3, 2022 Business Services, Medical Communications

A study published in Jama Network Open has revealed that Johnson & Johnson’s coronavirus vaccine was far less effective at …
News

FDA grants breakthrough therapy designation to RSV vaccine

March 3, 2022 Business Services, Medical Communications

The FDA has granted a Breakthrough Therapy Designation to Pfizer’s respiratory syncytial virus (RSV) vaccine candidate, for the prevention of …
News

WHO recommends Merck’s COVID-19 pill

March 3, 2022 Business Services, Medical Communications

WHO have recommended Merck’s pill, molnupiravir, for the treatment of COVID-19 in patients in high risk groups, such as the …
News

Study reveals potential genetic determinants of unexplained child deaths

February 25, 2022 Medical Communications

Various genetic determinants may cause a predisposition to Sudden Unexpected Death in Paediatrics (SUPD), which encompasses syndromes such as Sudden …
News
sydney-rae-jk6kt2jmy4w-unsplash

NICE draft guidance recommends tucatinib for advanced breast cancer

February 25, 2022 Medical Communications

Roughly 400 people with advanced breast cancer are set to benefit from a new treatment, following the NICE publication of …
News

CHMP recommends QUVIVIQ in Europe as a new treatment for adult insomnia patients

February 25, 2022 Medical Communications

The CHMP has adopted a positive opinion for the use of QUVIVIQ for the treatment of adult patients with insomnia. …
News

Plant-based COVID-19 vaccine approved

February 25, 2022 Medical Communications

Medicago and GlaxoSmithKline (GSK) have announced the approval by Health Canada of COVIFENZ®, a COVID-19 vaccine manufactured in plants, with …
News

Study shows antibiotics affect gut microbes of newborns

February 18, 2022 Medical Communications

Researchers from the Universities of Edinburgh and Birmingham, with the Spaarne Hospital and University Medical Centre Utrecht, Netherlands, have conducted …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026